These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 37629000)

  • 1. Bridging the Gap between Gut Microbiota and Alzheimer's Disease: A Metaproteomic Approach for Biomarker Discovery in Transgenic Mice.
    Ayan E; DeMirci H; Serdar MA; Palermo F; Baykal AT
    Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37629000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MetaProClust-MS1: an MS1 Profiling Approach for Large-Scale Microbiome Screening.
    Simopoulos CMA; Ning Z; Li L; Khamis MM; Zhang X; Lavallée-Adam M; Figeys D
    mSystems; 2022 Aug; 7(4):e0038122. PubMed ID: 35950762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alterations in the Gut-Microbial-Inflammasome-Brain Axis in a Mouse Model of Alzheimer's Disease.
    Shukla PK; Delotterie DF; Xiao J; Pierre JF; Rao R; McDonald MP; Khan MM
    Cells; 2021 Apr; 10(4):. PubMed ID: 33916001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dynamic distribution of gut microbiota during Alzheimer's disease progression in a mice model.
    Zhu J; Liu S; Zhang H; Zhao W; Ding J; Dai R; Xu K; He C; Liu J; Yang L; Meng H
    APMIS; 2023 Sep; 131(9):480-490. PubMed ID: 37365713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alzheimer's Disease Histological and Behavioral Manifestations in Transgenic Mice Correlate with Specific Gut Microbiome State.
    Shen L; Liu L; Ji HF
    J Alzheimers Dis; 2017; 56(1):385-390. PubMed ID: 27911317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Shifts in gut microbiota composition in an APP/PSS1 transgenic mouse model of Alzheimer's disease during lifespan.
    Bäuerl C; Collado MC; Diaz Cuevas A; Viña J; Pérez Martínez G
    Lett Appl Microbiol; 2018 Jun; 66(6):464-471. PubMed ID: 29575030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deciphering the intricate linkage between the gut microbiota and Alzheimer's disease: Elucidating mechanistic pathways promising therapeutic strategies.
    Liang J; Wang Y; Liu B; Dong X; Cai W; Zhang N; Zhang H
    CNS Neurosci Ther; 2024 Apr; 30(4):e14704. PubMed ID: 38584341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Periodontitis-related salivary microbiota aggravates Alzheimer's disease via gut-brain axis crosstalk.
    Lu J; Zhang S; Huang Y; Qian J; Tan B; Qian X; Zhuang J; Zou X; Li Y; Yan F
    Gut Microbes; 2022; 14(1):2126272. PubMed ID: 36175166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mild cognitive impairment has similar alterations as Alzheimer's disease in gut microbiota.
    Li B; He Y; Ma J; Huang P; Du J; Cao L; Wang Y; Xiao Q; Tang H; Chen S
    Alzheimers Dement; 2019 Oct; 15(10):1357-1366. PubMed ID: 31434623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gut Microbiota Composition and Epigenetic Molecular Changes Connected to the Pathogenesis of Alzheimer's Disease.
    Nagu P; Parashar A; Behl T; Mehta V
    J Mol Neurosci; 2021 Jul; 71(7):1436-1455. PubMed ID: 33829390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transplantation of gut microbiota derived from Alzheimer's disease mouse model impairs memory function and neurogenesis in C57BL/6 mice.
    Kim N; Jeon SH; Ju IG; Gee MS; Do J; Oh MS; Lee JK
    Brain Behav Immun; 2021 Nov; 98():357-365. PubMed ID: 34500036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Longitudinal Analysis of the Microbiome and Metabolome in the 5xfAD Mouse Model of Alzheimer's Disease.
    Dunham SJB; McNair KA; Adams ED; Avelar-Barragan J; Forner S; Mapstone M; Whiteson KL
    mBio; 2022 Dec; 13(6):e0179422. PubMed ID: 36468884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current understanding of the Alzheimer's disease-associated microbiome and therapeutic strategies.
    Seo DO; Holtzman DM
    Exp Mol Med; 2024 Feb; 56(1):86-94. PubMed ID: 38172602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of serotonin within the microbiota-gut-brain axis in the development of Alzheimer's disease: A narrative review.
    Aaldijk E; Vermeiren Y
    Ageing Res Rev; 2022 Mar; 75():101556. PubMed ID: 34990844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mannan oligosaccharide attenuates cognitive and behavioral disorders in the 5xFAD Alzheimer's disease mouse model via regulating the gut microbiota-brain axis.
    Liu Q; Xi Y; Wang Q; Liu J; Li P; Meng X; Liu K; Chen W; Liu X; Liu Z
    Brain Behav Immun; 2021 Jul; 95():330-343. PubMed ID: 33839232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deep proteome profiling of the hippocampus in the 5XFAD mouse model reveals biological process alterations and a novel biomarker of Alzheimer's disease.
    Kim DK; Han D; Park J; Choi H; Park JC; Cha MY; Woo J; Byun MS; Lee DY; Kim Y; Mook-Jung I
    Exp Mol Med; 2019 Nov; 51(11):1-17. PubMed ID: 31727875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gut microbiota-driven metabolic alterations reveal gut-brain communication in Alzheimer's disease model mice.
    Chen Y; Li Y; Fan Y; Chen S; Chen L; Chen Y; Chen Y
    Gut Microbes; 2024; 16(1):2302310. PubMed ID: 38261437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of gut-brain axis, gut microbial composition, and probiotic intervention in Alzheimer's disease.
    Kesika P; Suganthy N; Sivamaruthi BS; Chaiyasut C
    Life Sci; 2021 Jan; 264():118627. PubMed ID: 33169684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isoorientin Affects Markers of Alzheimer's Disease via Effects on the Oral and Gut Microbiota in APP/PS1 Mice.
    Zhang Z; Tan X; Sun X; Wei J; Li QX; Wu Z
    J Nutr; 2022 Jan; 152(1):140-152. PubMed ID: 34636875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gut Microbiota and Immunotherapy for Alzheimer's Disease.
    Dai CL; Liu F; Iqbal K; Gong CX
    Int J Mol Sci; 2022 Dec; 23(23):. PubMed ID: 36499564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.